参考文献/References:
[1]Gupta G,Kuppachi S,Kalil RS,et al.Treatment for Presumed BK Polyomavirus Nephropathy and Risk of Urinary Tract Cancers among Kidney Transplant Recipients in the United States[J].American Journal of Transplantation,2018,18(1):245-252.[2]Liu S,Chaudhry MR,Berrebi AA,et al.Polyomavirus Replication and Smoking Are Independent Risk Factors for Bladder Cancer After Renal Transplantation[J].Transplantation,2016,101(6):1.[3]Tremolada S,Akan S,Otte J,et al.Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy[J].Virology,2010,404(2):312-318. [4]O’Hara SD,Stehle T,Garcea R.Glycan receptors of the Polyomaviridae:structure,function,and pathogenesis[J].Current Opinion in Virology,2014(7):73-78. [5]Bofill-Mas S,Formiga-Cruz M,Clemente-Casares P,et al.Potential Transmission of Human Polyomaviruses through the Gastrointestinal Tract after Exposure to Virions or Viral DNA[J].Journal of Virology,2001,75(21):10290-10299. [6]Cobos M,Aquilia L,Garay E,et al.Epidemiologic Study and Genotyping of BK Virus in Renal Transplant Recipients[J].Transplant Proc,2018,50(2):458-460. [7]El Ansary M,Abd Elhamid S,Saadi G,et al.Prevalence of polyoma BK virus infection among living-donor renal transplant recipients[J].Transpl Infect Dis,2016,18(4):529-537.[8]Nankivell BJ,Renthawa J,Sharma RN,et al.BK virus nephropathy: histological evolution by sequential pathology[J].American Journal of Transplantation,2017,17(8):2065-2077.[9]Elfadawy N,Flechner SM,Liu X,et al.The impact of surveillance and rapid reduction in immunosuppression to control BK virusrelated graft injury in kidney transplantation[J].Transpl Int,2013,26(8):822-832.[10]Sood P,Senanayake S,Sujeet K,et al.Donor and Recipient BKV-Specific IgG Antibody and Posttransplantation BKV Infection:A Prospective Single-Center Study [J].Transplantation,2013,95(6):896-902.[11]Acott PD,Hirsch HH.BK virus infection,replication,and diseases in pediatric kidney transplantation[J].Pediatric Nephrology,2007,22(9):1243-1250.[12]Masutani K,Shapiro R,Basu A,et al.The Banff 2009 Working Proposal for Polyomavirus Nephropathy:A Critical Evaluation of Its Utility as a Determinant of Clinical Outcome[J].American Journal of Transplantation,2012,12(4):907-918.[13]Mitterhofer AP,Tinti F,Pietropaolo V,et al.Role of BK virus infection in end-stage renal disease patients waiting for kidney transplantation - viral replication dynamics from pre- to post-transplant[J].Clin Transpl,2014,28(3):299-306.[14]Solis M,Velay A,Porcher R,et al.Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy[J].J Am Soc Nephrol,2018,29(1):326-334.[15]Drachenberg CB,Papadimitriou JC,Hirsch HH,et al.Histological Patterns of Polyomavirus Nephropathy:Correlation with Graft Outcome and Viral Load[J].American Journal of Transplantation,2004,4(12):2082-2092.[16]Rogers R,Gohh R,Noska A.Urothelial cell carcinoma after BK polyomavirus infection in kidney transplant recipients:a cohort study of veterans[J].Transpl Infect Dis,2017,19(5):e12752.[17]Greer AE,Forman MS,Valsamakis A,et al.Comparison of BKV quantifification using a single automated nucleic acid extraction platform and realtime PCR assays[J].Diagn Microbiol Infect Dis,2015,82(4):297-302.[18]Schachtner T,Stein M,Babel N,et al.The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication[J].American Journal of Transplantation,2015,15(8):2159-2169.[19]马锡慧,高钰,韩永,等.流式细胞术在肾移植术后感染中的诊断价值[J].器官移植,2018,9(2):136-141.[20]Tan Susanna K,Huang C,Sahoo MK,et al.Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients[J].Infectious Diseases Society of America Dis,2019,220(3):370-376.[21]Schachtner T,Stein M,Sefrin A,et al.Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation[J].Transplant International,2014,27(3):290-301.[22]Mutlu E,K?ksoy S,Mutlu D,et al.Quantitative analysis of BKV-specific CD4+ T cells before and after kidney transplantation[J].Transplant Immunology,2015,33(1):20-26. [23]Huang J,Danovitch G,Pham PT,et al.Kidney retransplantation for BK virus nephropathy with active viremia without allograft nephrectomy[J].Journal of Nephrology,2015,28(6):773-777. [24]Bucsa C,Stefan G,Tacu D,et al.Does the KDIGO CKD risk stratification based on GFR and proteinuria predict kidney graft failure[J].Int Urol Nephrol,2014,46(9):1857-1865.[25]An P,Sáenz Robles,Maria Teresa,et al.Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence[J].PLoS Pathog,2019,15(1):e1007505.[26]Elfadawy N,Yamada M,Sarabu N.Management of BK Polyomavirus Infection in Kidney and Kidney-Pancreas Transplant Recipients:A Review Article[J].Infect Dis Clin North Am,2018,32(3):599-613.[27]Hirsch HH,Randhawa P,AST Infect Dis Community Practice.BK polyomavirus in solid organ transplantation[J].Am J Transplant,2013,13(Suppl 4):179-188.[28]Bischof N,Hirsch HH,Wehmeier C,et al.Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation:long-term outcomes[J].Nephrology Dialysis Transplantation,2019,34(7):1240-1250.[29]Krisl JC,Taber DJ,Pilch N,et al.Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection[J].Clin J Am Soc Nephrol,2012,7(6):1003-1009. [30]Andrei G,Van Loon E,Lerut E,et al.Persistent primary cytomegalovirus infection in a kidney transplant recipient:Multi-drug resistant and compartmentalized infection leading to graft loss[J].Antiviral Research,2019(168):203-209.[31]Velay A,Solis M,Benotmane I,et al.Intravenous Immunoglobulin(IVIg)Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant Recipients[J].Antimicrob Agents Chemother,2019,63(8):393-419.[32]Wojciechowski D,Chanda R,Chandran S,et al.Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year[J].Transplantation,2012,94(11):1117-1121.[33]Lebreton M,Esposito L,Mengelle C,et al.A 3-month course of ciprofloxacin does not prevent BK virus replication in heavily immunosuppressed kidney-transplant patients[J].Clin Virol,2016(79):61-67.[34]Yen CL,Tian YC,Wu HH,et al.Conversion to mTOR-inhibitors with calcineurin inhibitor elimination or minimization reduces urinary polyomavirus BK load in kidney transplant recipients[J].Journal of the Formosan Medical Association,2016,115(7):539-546.[35]邓伟明,刘燕娜,于立新.早期干预BK病毒复制有利于维持移植肾功能的稳定[J].南方医科大学学报,2017,37(8):1110-1115.
相似文献/References:
[1]李 茂,康 简,梁思敏.颅内出血心脑死亡器官捐献供体的安全性评估[J].医学信息,2018,31(07):53.[doi:10.3969/j.issn.1006-1959.2018.07.018]
LI Mao,KANG Jian,LIANG Si-min.Evaluation of the Safety of Intracranial Hemorrhage Donors for Organ Donation[J].Medical Information,2018,31(05):53.[doi:10.3969/j.issn.1006-1959.2018.07.018]
[2]王俊全,祝清国.肾移植术后感染性腹泻的诊疗分析[J].医学信息,2019,32(02):51.[doi:10.3969/j.issn.1006-1959.2019.02.017]
WANG Jun-quan,ZHU Qing-guo.Diagnosis and Treatment of Infectious Diarrhea after Renal Transplantation[J].Medical Information,2019,32(05):51.[doi:10.3969/j.issn.1006-1959.2019.02.017]
[3]王 畅,祝清国.肾移植术后尿路上皮癌发病特点的文献统计分析[J].医学信息,2018,31(13):123.[doi:10.3969/j.issn.1006-1959.2018.13.036]
WANG Chang,ZHU Qing-guo.Literature and Statistical Analysis of the Characteristics of Urothelial Carcinoma after Renal Transplantation[J].Medical Information,2018,31(05):123.[doi:10.3969/j.issn.1006-1959.2018.13.036]
[4]张建强,蒋 鹏,顾新伟,等.公民逝世后器官捐献合并AKI供体肾移植的疗效观察[J].医学信息,2019,32(12):96.[doi:10.3969/j.issn.1006-1959.2019.12.029]
ZHANG Jian-qiang,JIANG Peng,GU Xin-wei,et al.Therapeutic Effect of Organ Donation Combined with AKI Donor Kidney Transplantation after the Death of Citizens[J].Medical Information,2019,32(05):96.[doi:10.3969/j.issn.1006-1959.2019.12.029]
[5]董 梅,顾云娜,李兴勤,等.蛋白A免疫吸附清除致敏肾移植受者HLA抗体的临床观察[J].医学信息,2023,36(06):101.[doi:10.3969/j.issn.1006-1959.2023.06.022]
DONG Mei,GU Yun-na,LI Xing-qin,et al.Clinical Observation of the Clearance of HLA Antibodies in Sensitized Renal Transplant Recipients by Protein A Immunoadsorption[J].Medical Information,2023,36(05):101.[doi:10.3969/j.issn.1006-1959.2023.06.022]